查看購物車
  • Simplified Chinese
  • English
  • Japanese
處方藥市場規模及預測 2021-2031、全球及地區佔有率、趨勢及成長機會分析報告涵蓋：產品類型、藥物類型、治療領域、給藥途徑、配銷通路及地理
市場調查報告書
商品編碼
1780283

處方藥市場規模及預測 2021-2031、全球及地區佔有率、趨勢及成長機會分析報告涵蓋：產品類型、藥物類型、治療領域、給藥途徑、配銷通路及地理

Prescription Drugs Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product Type, Drug Type, Therapeutic Area, Route Of Administration, Distribution Channel, and Geography
出版日期: | 出版商: The Insight Partners | 英文 329 Pages | 訂單完成後即時交付

價格

依據「2031 年處方藥市場預測 - 全球分析 - 按產品類型、藥物類型、給藥途徑、治療領域和配銷通路」的新研究，預計市場規模將從 2024 年的 14,407.9 億美元成長到 2031 年的 23,501.2 億美元；預計 2025 年至 2031 年的複合年成長率為 203%。處方藥市場的成長歸因於慢性病盛行率的不斷上升以及創新藥物和特殊藥物的開發和應用。

處方藥是指依法需要持有執業醫療專業人員處方才能購買的藥物。由於處方藥可能對人體產生重大影響、需要安全監測或有濫用風險，因此受到監管。

北美處方藥市場分為美國、加拿大和墨西哥。北美很可能佔據全球市場的很大佔有率。主要促進因素之一是該地區的人口老化。隨著嬰兒潮世代逐漸老去，糖尿病、心血管疾病和癌症等慢性病的發生率也隨之上升，刺激了處方藥的需求。

藥物研究和生物技術的進步也發揮了關鍵作用。包括生物製劑和個人化醫療在內的藥物開發創新拓展了治療選擇，提高了療效和安全性。針對先前無法治癒的疾病的新型療法的引入進一步推動了市場成長。

另一個主要因素是北美強大的醫療基礎設施，這得益於對醫療機構、保險覆蓋和藥品分銷網路的大量投資。醫療服務的普及以及病患疾病管理意識的提高，增加了處方藥的消費。此外，美國食品藥物管理局 (FDA) 等機構的監管支持加快了創新藥物的核准流程，使其能夠更快進入市場。此外，旨在擴大醫療保險覆蓋範圍的政府舉措，例如美國的《平價醫療法案》，也增加了更廣泛人群獲得處方藥的機會。

此外，生活方式相關疾病的增加以及精神健康障礙的盛行率上升，也導致了對治療藥物的持續需求。新冠疫情也凸顯了藥物介入的重要性，加速了對藥物研發和分銷的投資。

在北美，美國佔據了處方藥市場的很大佔有率。癌症、心臟病和糖尿病等慢性疾病導致處方藥需求不斷增加。心臟病仍然是美國最大的死亡原因，每年有近一百萬美國人死於心血管疾病 (CVD)。根據美國心臟協會統計，近一半的美國成年人患有某種類型的心血管疾病 (CVD)，預計到 2035 年，患有心臟衰竭的成年人數量將會增加。預計到 2035 年，將有超過 1.3 億成年人（占美國人口的 45.1%）患有某種形式的心血管疾病。心血管疾病病例的激增導致需要長期藥物管理的患者數量增加，包括他汀類藥物、BETA 受體阻斷劑、抗凝血劑和抗高血壓藥物。

根據美國癌症協會統計，2022 年美國新增癌症病例約 190 萬例，癌症導致約 61 萬人死亡。隨著癌症病例的增加，對創新治療方案的需求也上升。治療性疫苗為傳統療法提供了一個有希望的替代方案。 2010 年獲得 FDA 批准的 Provenge (sipuleucel-T) 是第一個獲得批准並成為癌症治療處方藥的治療性癌症疫苗。此外，腫瘤學、免疫學和基因療法的進步正在擴大各種癌症和自體免疫疾病的治療選擇。儘管取得了這些進步，處方藥支出仍在持續上升。根據美國衛生系統藥劑師協會統計，2024 年美國人在處方藥上的支出為 8,059 億美元，比前一年增加 10.2%。這一成長歸因於對這些藥物的需求增加以及新的昂貴治療方法的推出。此外，79%的美國人認為處方藥價格“不合理”，而70%的人認為降低這些成本是他們的首要醫療保健重點。根據蘭德公司的數據，美國處方藥價格平均比其他32個經濟合作暨發展組織（OECD）成員國高出2.56倍，品牌藥價格更是高出3.44倍。為了解決這些成本問題，旨在協商聯邦醫療保險（Medicare）藥品價格的《通貨膨脹削減法案》（IRA）應運而生。 2024年，美國政府最終確定了《通貨膨脹削減法案2022》中首批十種藥品的價格，這是一個重要的里程碑。經過數月與藥品製造商的談判，Stelara和Jardiance等藥品的價格已下調38%至79%。預計到2026年，這些變化將為納稅人節省60億美元，並為患者節省15億美元。

在支出持續成長的同時，立法工作也在進行中，旨在讓美國人更負擔得起藥物。 2025年5月，唐納德·川普總統簽署了一項行政命令，題為「向美國患者提供最惠國處方藥定價」。川普表示，該命令旨在使美國人和納稅人支付的處方藥價格與同類國家的價格保持一致。預計該措施將使藥價至少降低50%，並被認為是川普2020年最惠國模式的更激進版本。

個人化和精準醫療的成長為未來提供市場機會

個人化醫療和精準醫療正經歷技術進步的不斷推進，人們對基因組學的理解日益加深，個人化治療方法的應用也日益廣泛。個人化醫療是指根據個人基因、環境和生活方式因素量身訂做醫療保健，從而實現更有效、更有針對性的治療。曲妥珠單抗（赫賽汀）等針對 HER2 陽性乳癌的標靶癌症療法的開發，體現了基因分析如何識別最能從特定治療中獲益的患者，從而提高療效並減少不良反應。伴隨診斷的日益普及有望將基因檢測整合到常規臨床實踐中，從而提高藥物的療效和安全性。

人工智慧 (AI) 和巨量資料分析等技術進步正在加速個人化醫療的探索。人工智慧驅動的演算法能夠分析大量資料集，預測個體對藥物的反應，識別新的治療標靶，並簡化藥物開發流程。例如，Tempus 等公司正在利用人工智慧根據患者的基因圖譜來客製化癌症治療方案，提供更精準、更有效的干涉措施。因此，技術創新以及更有效、更安全、以患者為中心的療法在臨床上的廣泛應用，將改變全球醫療服務的提供方式和療效，預計將在未來幾年推動市場成長。

美國食品藥物管理局、國家癌症研究所、歐洲藥品管理局、中央藥品標準控制組織和我們的世界資料是編寫處方藥市場報告時參考的主要和次要來源。

目錄

第1章：簡介

第2章：執行摘要

  • 分析師市場展望

第3章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：
  • 假設和局限性

第4章：處方藥市場格局

  • 概述
  • PEST分析

第5章：處方藥市場－關鍵市場動態

  • 處方藥市場－關鍵市場動態
  • 市場促進因素：
    • 慢性疾病盛行率不斷上升
    • 創新藥物和特殊藥物的開發和應用
  • 市場限制
    • 藥價高昂，且難以負擔
  • 市場機會
    • 市場參與者的策略性舉措
  • 未來趨勢
    • 個人化和精準醫療的發展
  • 促進因素和限制因素的影響：

第6章：處方藥市場－全球市場分析

  • 處方藥市場收入（2021-2031）
  • 處方藥市場預測分析

第7章：處方藥市場分析－依產品類型

  • 品牌
  • 泛型

第 8 章：處方藥市場分析 - 依藥品類型

  • 小分子
  • 生物製劑和生物相似藥

第9章：處方藥市場分析－依治療領域

  • 腫瘤學
  • 心血管疾病
  • 神經系統疾病
  • 代謝性疾病
  • 呼吸系統疾病
  • 免疫學
  • 其他

第 10 章：處方藥市場分析 - 按給藥途徑

  • 口服
  • 注射劑
  • 外用
  • 其他

第 11 章：處方藥市場分析 - 按配銷通路

  • 醫院藥房
  • 零售藥局
  • 網路藥局

第 12 章：處方藥市場 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 13 章：競爭格局

  • 關鍵參與者的熱圖分析
  • 公司定位與集中度

第 14 章：產業格局

  • 概述
  • 處方藥市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第15章：公司簡介

  • Johnson & Johnson
  • Pfizer Inc
  • Merck & Co Inc
  • Eli Lilly and Co
  • ESTEVE
  • AstraZeneca Plc
  • Sanofi SA
  • GSK Plc
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • AbbVie Inc
  • Teva Pharmaceutical Industries Ltd

第 16 章：附錄

Product Code: TIPRE00040966

According to our new research study on "Prescription Drugs Market Forecast to 2031 -Global Analysis - by Product Type, Drug Type, Route Of Administration, Therapeutic Area, And Distribution Channel," the market is anticipated to grow from US$ 1,440.79 billion in 2024 and is projected to reach US$ 2,350.12 billion by 2031; it is expected to register a CAGR of 7.3% from 2025 to 2031. The prescription drugs market growth is attributed to the increasing prevalence of chronic disorders and development and adoption of innovative and specialty drugs.

Prescription drugs are medications that legally require a medical prescription from a licensed healthcare professional. They are regulated because they can have significant effects on the body, require monitoring for safety, or have potential for misuse.

The prescription drugs market in North America is segmented into the US, Canada, and Mexico. North America is likely to capture a significant share of the global market. One of the primary drivers is the region's aging population. As the baby boomer generation grows older, the prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer has increased, thereby boosting the demand for prescription medications.

Advancements in pharmaceutical research and biotechnology have also played a critical role. Innovations in drug development, including biologics and personalized medicine, have expanded treatment options, enhancing efficacy and safety. The introduction of novel therapies for previously untreatable conditions has further propelled market growth.

Another major contributor is the strong healthcare infrastructure in North America, supported by substantial investments in healthcare facilities, insurance coverage, and pharmaceutical distribution networks. The widespread availability of healthcare services and better patient awareness about disease management have increased prescription drug consumption. Additionally, regulatory support from agencies such as the US Food and Drug Administration (FDA) facilitates quicker approval processes for innovative drugs, enabling faster market entry. Furthermore, government initiatives aimed at expanding healthcare coverage, such as the Affordable Care Act in the US, have increased access to prescription drugs for a broader population.

Also, the rise in lifestyle-related diseases and increased prevalence of mental health disorders have created a sustained demand for therapeutic drugs. The COVID-19 pandemic also emphasized the importance of pharmaceutical interventions, accelerating investments in drug development and distribution.

In North America, the US holds a significant share of the prescription drugs market. Chronic conditions such as cancer, heart disease, and diabetes are contributing to the rising demand for prescription medications. Heart disease remains the leading cause of death in the US, with nearly one million Americans annually succumbing to cardiovascular disease (CVD). According to the American Heart Association, nearly half of all adults in the US have some type of CVD, and it is estimated that the number of adults suffering from heart failure is projected to increase by 2035. Over 130 million adults, i.e., 45.1% of the US population, are expected to report some form of CVD by 2035. This surge in CVD cases leads to a higher number of patients requiring long-term medication management, including statins, beta-blockers, anticoagulants, and antihypertensive drugs.

According to the American Cancer Society, in 2022, ~1.9 million new cases of cancer were diagnosed in the country, and it caused ~0.61 million deaths. With the increasing cases of cancer, the demand for innovative treatment options is rising. Therapeutic vaccines offer promising alternatives to traditional therapies. Provenge (sipuleucel-T), approved by the FDA in 2010, is the first therapeutic cancer vaccine to receive approval and prescribed medication for cancer treatment. Additionally, advancements in oncology, immunology, and gene therapies are expanding treatment options for various cancers and autoimmune diseases. Despite these advancements, prescription drug spending continues to rise. According to the American Society of Health-System Pharmacists, in 2024, Americans spent US$ 805.9 billion on prescription drugs, a 10.2% increase from the previous year. This increase is attributed to higher demand for these medications and the introduction of new, expensive treatments. Additionally, 79% of Americans believe that prescription drug prices are "unreasonable," while 70% consider reducing these costs to be their top healthcare priority. According to the Rand Corporation, on average, prescription drug prices in the US are 2.56 times higher than those in 32 other Organization for Economic Co-operation and Development (OECD) countries, with brand-name medications costing 3.44 times more. To address these costs, the Inflation Reduction Act (IRA), which aims to negotiate drug prices for Medicare, was introduced. In 2024, the US government finalized prices for the first ten drugs under the IRA 2022, marking a significant milestone. After months of negotiations with drug manufacturers, prices for medications such as Stelara and Jardiance have reduced by 38% to 79%. These changes are anticipated to save taxpayers US$6 billion by 2026 and provide US$1.5 billion in savings for patients.

While spending continues to rise, legislative efforts are underway to make medications more affordable for Americans. In May 2025, President Donald Trump signed an executive order titled "Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients." Trump stated that the order aims to align the prices Americans and taxpayers pay for prescription drugs with those paid in comparable countries. The measure is expected to cut drug prices by at least 50% and is characterized as a more aggressive version of Trump's 2020 Most Favored Nation model.

Growth of Personalized and Precision Medicine to Provide Market Opportunities in Future

Personalized and precision medicine is experiencing growing technological advancements, increasing understanding of genomics, and rising adoption of personalized therapeutic approaches. Personalized medicine involves customizing healthcare based on individual genetic, environmental, and lifestyle factors, allowing for more effective and targeted treatments. The development of targeted cancer therapies such as trastuzumab (Herceptin) for HER2-positive breast cancer exemplifies how genetic profiling can identify patients who will benefit most from specific treatments, improving efficacy and reducing adverse effects. The increasing adoption of companion diagnostics is expected to integrate genetic testing into routine clinical practice, enhancing drug efficacy and safety.

Technological advancements such as artificial intelligence (AI) and big data analytics are accelerating discoveries in personalized medicine. AI-driven algorithms analyze vast datasets to predict individual responses to drugs, identify new therapeutic targets, and streamline drug development processes. For instance, companies such as Tempus are harnessing AI to tailor cancer treatments based on patients' genetic profiles, offering more precise and effective interventions. Therefore, technological innovations and increasing clinical adoption of more effective, safer, and patient-centric therapies, transforming healthcare delivery and outcomes globally, are expected to contribute to the market growth in coming years.

The US Food and Drug Administration, National Cancer Institute, European Medicines Agency, Central Drugs Standard Control Organization, and Our World in data are among the primary and secondary sources referred to while preparing the prescription drugs market report.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Analyst Market Outlook

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:
  • 3.3 Assumptions and Limitations

4. Prescription Drugs Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Prescription Drugs Market - Key Market Dynamics

  • 5.1 Prescription Drugs Market - Key Market Dynamics
  • 5.2 Market Drivers:
    • 5.2.1 Increasing Prevalence of Chronic Disorders
    • 5.2.2 Development and Adoption of Innovative and Specialty Drugs
  • 5.3 Market Restraints
    • 5.3.1 High Drug Prices and Affordability Issues
  • 5.4 Market Opportunities
    • 5.4.1 Strategic Initiatives by Market Players
  • 5.5 Future Trends
    • 5.5.1 Growth of Personalized and Precision Medicine
  • 5.6 Impact of Drivers and Restraints:

6. Prescription Drugs Market - Global Market Analysis

  • 6.1 Prescription Drugs Market Revenue (US$ Billion), 2021-2031
  • 6.2 Prescription Drugs Market Forecast Analysis

7. Prescription Drugs Market Analysis - by Product Type

  • 7.1 Branded
    • 7.1.1 Overview
    • 7.1.2 Branded: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 7.2 Generics
    • 7.2.1 Overview
    • 7.2.2 Generics: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)

8. Prescription Drugs Market Analysis - by Drug Type

  • 8.1 Small Molecule
    • 8.1.1 Overview
    • 8.1.2 Small Molecule: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 8.2 Biologics and Biosimilar
    • 8.2.1 Overview
    • 8.2.2 Biologics and Biosimilar: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)

9. Prescription Drugs Market Analysis - by Therapeutic Area

  • 9.1 Oncology
    • 9.1.1 Overview
    • 9.1.2 Oncology: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 9.2 Cardiovascular Diseases
    • 9.2.1 Overview
    • 9.2.2 Cardiovascular Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 9.3 Neurological Diseases
    • 9.3.1 Overview
    • 9.3.2 Neurological Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 9.4 Metabolic Diseases
    • 9.4.1 Overview
    • 9.4.2 Metabolic Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 9.5 Respiratory Diseases
    • 9.5.1 Overview
    • 9.5.2 Respiratory Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 9.6 Immunology
    • 9.6.1 Overview
    • 9.6.2 Immunology: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 9.7 Others
    • 9.7.1 Overview
    • 9.7.2 Others: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)

10. Prescription Drugs Market Analysis - by Route Of Administration

  • 10.1 Oral
    • 10.1.1 Overview
    • 10.1.2 Oral: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 10.2 Injectable
    • 10.2.1 Overview
    • 10.2.2 Injectable: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 10.3 Topical
    • 10.3.1 Overview
    • 10.3.2 Topical: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 10.4 Others
    • 10.4.1 Overview
    • 10.4.2 Others: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)

11. Prescription Drugs Market Analysis - by Distribution Channel

  • 11.1 Hospital Pharmacies
    • 11.1.1 Overview
    • 11.1.2 Hospital Pharmacies: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 11.2 Retail Pharmacies
    • 11.2.1 Overview
    • 11.2.2 Retail Pharmacies: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 11.3 Online Pharmacies
    • 11.3.1 Overview
    • 11.3.2 Online Pharmacies: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)

12. Prescription Drugs Market - Geographical Analysis

  • 12.1 North America
    • 12.1.1 North America Prescription Drugs Market Overview
    • 12.1.2 North America: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
      • 12.1.2.1 North America: Prescription Drugs Market - Revenue and Forecast Analysis - by Product Type
      • 12.1.2.2 North America: Prescription Drugs Market - Revenue and Forecast Analysis - by Drug Type
      • 12.1.2.3 North America: Prescription Drugs Market - Revenue and Forecast Analysis - by Therapeutic Area
      • 12.1.2.4 North America: Prescription Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
      • 12.1.2.5 North America: Prescription Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
    • 12.1.3 North America: Prescription Drugs Market - Revenue and Forecast Analysis - by Country
      • 12.1.3.1 United States: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.1.3.1.1 United States: Prescription Drugs Market Breakdown, by Product Type
        • 12.1.3.1.2 United States: Prescription Drugs Market Breakdown, by Drug Type
        • 12.1.3.1.3 United States: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.1.3.1.4 United States: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.1.3.1.5 United States: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.1.3.2 Canada: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.1.3.2.1 Canada: Prescription Drugs Market Breakdown, by Product Type
        • 12.1.3.2.2 Canada: Prescription Drugs Market Breakdown, by Drug Type
        • 12.1.3.2.3 Canada: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.1.3.2.4 Canada: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.1.3.2.5 Canada: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.1.3.3 Mexico: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.1.3.3.1 Mexico: Prescription Drugs Market Breakdown, by Product Type
        • 12.1.3.3.2 Mexico: Prescription Drugs Market Breakdown, by Drug Type
        • 12.1.3.3.3 Mexico: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.1.3.3.4 Mexico: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.1.3.3.5 Mexico: Prescription Drugs Market Breakdown, by Distribution Channel
  • 12.2 Europe
    • 12.2.1 Europe Prescription Drugs Market Overview
    • 12.2.2 Europe: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
      • 12.2.2.1 Europe: Prescription Drugs Market - Revenue and Forecast Analysis - by Product Type
      • 12.2.2.2 Europe: Prescription Drugs Market - Revenue and Forecast Analysis - by Drug Type
      • 12.2.2.3 Europe: Prescription Drugs Market - Revenue and Forecast Analysis - by Therapeutic Area
      • 12.2.2.4 Europe: Prescription Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
      • 12.2.2.5 Europe: Prescription Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
    • 12.2.3 Europe: Prescription Drugs Market - Revenue and Forecast Analysis - by Country
      • 12.2.3.1 Germany: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.2.3.1.1 Germany: Prescription Drugs Market Breakdown, by Product Type
        • 12.2.3.1.2 Germany: Prescription Drugs Market Breakdown, by Drug Type
        • 12.2.3.1.3 Germany: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.2.3.1.4 Germany: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.2.3.1.5 Germany: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.2.3.2 United Kingdom: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.2.3.2.1 United Kingdom: Prescription Drugs Market Breakdown, by Product Type
        • 12.2.3.2.2 United Kingdom: Prescription Drugs Market Breakdown, by Drug Type
        • 12.2.3.2.3 United Kingdom: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.2.3.2.4 United Kingdom: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.2.3.2.5 United Kingdom: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.2.3.3 France: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.2.3.3.1 France: Prescription Drugs Market Breakdown, by Product Type
        • 12.2.3.3.2 France: Prescription Drugs Market Breakdown, by Drug Type
        • 12.2.3.3.3 France: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.2.3.3.4 France: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.2.3.3.5 France: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.2.3.4 Italy: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.2.3.4.1 Italy: Prescription Drugs Market Breakdown, by Product Type
        • 12.2.3.4.2 Italy: Prescription Drugs Market Breakdown, by Drug Type
        • 12.2.3.4.3 Italy: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.2.3.4.4 Italy: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.2.3.4.5 Italy: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.2.3.5 Spain: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.2.3.5.1 Spain: Prescription Drugs Market Breakdown, by Product Type
        • 12.2.3.5.2 Spain: Prescription Drugs Market Breakdown, by Drug Type
        • 12.2.3.5.3 Spain: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.2.3.5.4 Spain: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.2.3.5.5 Spain: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.2.3.6 Rest of Europe: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.2.3.6.1 Rest of Europe: Prescription Drugs Market Breakdown, by Product Type
        • 12.2.3.6.2 Rest of Europe: Prescription Drugs Market Breakdown, by Drug Type
        • 12.2.3.6.3 Rest of Europe: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.2.3.6.4 Rest of Europe: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.2.3.6.5 Rest of Europe: Prescription Drugs Market Breakdown, by Distribution Channel
  • 12.3 Asia Pacific
    • 12.3.1 Asia Pacific Prescription Drugs Market Overview
    • 12.3.2 Asia Pacific: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
      • 12.3.2.1 Asia Pacific: Prescription Drugs Market - Revenue and Forecast Analysis - by Product Type
      • 12.3.2.2 Asia Pacific: Prescription Drugs Market - Revenue and Forecast Analysis - by Drug Type
      • 12.3.2.3 Asia Pacific: Prescription Drugs Market - Revenue and Forecast Analysis - by Therapeutic Area
      • 12.3.2.4 Asia Pacific: Prescription Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
      • 12.3.2.5 Asia Pacific: Prescription Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
    • 12.3.3 Asia Pacific: Prescription Drugs Market - Revenue and Forecast Analysis - by Country
      • 12.3.3.1 China: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.3.3.1.1 China: Prescription Drugs Market Breakdown, by Product Type
        • 12.3.3.1.2 China: Prescription Drugs Market Breakdown, by Drug Type
        • 12.3.3.1.3 China: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.3.3.1.4 China: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.3.3.1.5 China: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.3.3.2 Japan: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.3.3.2.1 Japan: Prescription Drugs Market Breakdown, by Product Type
        • 12.3.3.2.2 Japan: Prescription Drugs Market Breakdown, by Drug Type
        • 12.3.3.2.3 Japan: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.3.3.2.4 Japan: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.3.3.2.5 Japan: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.3.3.3 India: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.3.3.3.1 India: Prescription Drugs Market Breakdown, by Product Type
        • 12.3.3.3.2 India: Prescription Drugs Market Breakdown, by Drug Type
        • 12.3.3.3.3 India: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.3.3.3.4 India: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.3.3.3.5 India: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.3.3.4 Australia: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.3.3.4.1 Australia: Prescription Drugs Market Breakdown, by Product Type
        • 12.3.3.4.2 Australia: Prescription Drugs Market Breakdown, by Drug Type
        • 12.3.3.4.3 Australia: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.3.3.4.4 Australia: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.3.3.4.5 Australia: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.3.3.5 South Korea: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.3.3.5.1 South Korea: Prescription Drugs Market Breakdown, by Product Type
        • 12.3.3.5.2 South Korea: Prescription Drugs Market Breakdown, by Drug Type
        • 12.3.3.5.3 South Korea: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.3.3.5.4 South Korea: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.3.3.5.5 South Korea: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.3.3.6 Rest of APAC: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.3.3.6.1 Rest of APAC: Prescription Drugs Market Breakdown, by Product Type
        • 12.3.3.6.2 Rest of APAC: Prescription Drugs Market Breakdown, by Drug Type
        • 12.3.3.6.3 Rest of APAC: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.3.3.6.4 Rest of APAC: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.3.3.6.5 Rest of APAC: Prescription Drugs Market Breakdown, by Distribution Channel
  • 12.4 Middle East and Africa
    • 12.4.1 Middle East and Africa Prescription Drugs Market Overview
    • 12.4.2 Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
      • 12.4.2.1 Middle East and Africa: Prescription Drugs Market - Revenue and Forecast Analysis - by Product Type
      • 12.4.2.2 Middle East and Africa: Prescription Drugs Market - Revenue and Forecast Analysis - by Drug Type
      • 12.4.2.3 Middle East and Africa: Prescription Drugs Market - Revenue and Forecast Analysis - by Therapeutic Area
      • 12.4.2.4 Middle East and Africa: Prescription Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
      • 12.4.2.5 Middle East and Africa: Prescription Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
    • 12.4.3 Middle East and Africa: Prescription Drugs Market - Revenue and Forecast Analysis - by Country
      • 12.4.3.1 Saudi Arabia: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.4.3.1.1 Saudi Arabia: Prescription Drugs Market Breakdown, by Product Type
        • 12.4.3.1.2 Saudi Arabia: Prescription Drugs Market Breakdown, by Drug Type
        • 12.4.3.1.3 Saudi Arabia: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.4.3.1.4 Saudi Arabia: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.4.3.1.5 Saudi Arabia: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.4.3.2 South Africa: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.4.3.2.1 South Africa: Prescription Drugs Market Breakdown, by Product Type
        • 12.4.3.2.2 South Africa: Prescription Drugs Market Breakdown, by Drug Type
        • 12.4.3.2.3 South Africa: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.4.3.2.4 South Africa: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.4.3.2.5 South Africa: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.4.3.3 United Arab Emirates: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.4.3.3.1 United Arab Emirates: Prescription Drugs Market Breakdown, by Product Type
        • 12.4.3.3.2 United Arab Emirates: Prescription Drugs Market Breakdown, by Drug Type
        • 12.4.3.3.3 United Arab Emirates: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.4.3.3.4 United Arab Emirates: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.4.3.3.5 United Arab Emirates: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.4.3.4 Rest of Middle East and Africa: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.4.3.4.1 Rest of Middle East and Africa: Prescription Drugs Market Breakdown, by Product Type
        • 12.4.3.4.2 Rest of Middle East and Africa: Prescription Drugs Market Breakdown, by Drug Type
        • 12.4.3.4.3 Rest of Middle East and Africa: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.4.3.4.4 Rest of Middle East and Africa: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.4.3.4.5 Rest of Middle East and Africa: Prescription Drugs Market Breakdown, by Distribution Channel
  • 12.5 South and Central America
    • 12.5.1 South and Central America Prescription Drugs Market Overview
    • 12.5.2 South and Central America: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
      • 12.5.2.1 South and Central America: Prescription Drugs Market - Revenue and Forecast Analysis - by Product Type
      • 12.5.2.2 South and Central America: Prescription Drugs Market - Revenue and Forecast Analysis - by Drug Type
      • 12.5.2.3 South and Central America: Prescription Drugs Market - Revenue and Forecast Analysis - by Therapeutic Area
      • 12.5.2.4 South and Central America: Prescription Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
      • 12.5.2.5 South and Central America: Prescription Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
    • 12.5.3 South and Central America: Prescription Drugs Market - Revenue and Forecast Analysis - by Country
      • 12.5.3.1 Brazil: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.5.3.1.1 Brazil: Prescription Drugs Market Breakdown, by Product Type
        • 12.5.3.1.2 Brazil: Prescription Drugs Market Breakdown, by Drug Type
        • 12.5.3.1.3 Brazil: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.5.3.1.4 Brazil: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.5.3.1.5 Brazil: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.5.3.2 Argentina: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.5.3.2.1 Argentina: Prescription Drugs Market Breakdown, by Product Type
        • 12.5.3.2.2 Argentina: Prescription Drugs Market Breakdown, by Drug Type
        • 12.5.3.2.3 Argentina: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.5.3.2.4 Argentina: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.5.3.2.5 Argentina: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.5.3.3 Rest of South and Central America: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.5.3.3.1 Rest of South and Central America: Prescription Drugs Market Breakdown, by Product Type
        • 12.5.3.3.2 Rest of South and Central America: Prescription Drugs Market Breakdown, by Drug Type
        • 12.5.3.3.3 Rest of South and Central America: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.5.3.3.4 Rest of South and Central America: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.5.3.3.5 Rest of South and Central America: Prescription Drugs Market Breakdown, by Distribution Channel

13. Competitive Landscape

  • 13.1 Heat Map Analysis by Key Players
  • 13.2 Company Positioning & Concentration

14. Industry Landscape

  • 14.1 Overview
  • 14.2 Growth Strategies in the Prescription Drugs Market
  • 14.3 Organic Growth Strategies
    • 14.3.1 Overview
  • 14.4 Inorganic Growth Strategies
    • 14.4.1 Overview

15. Company Profiles

  • 15.1 Johnson & Johnson
    • 15.1.1 Key Facts
    • 15.1.2 Business Description
    • 15.1.3 Products and Services
    • 15.1.4 Financial Overview
    • 15.1.5 SWOT Analysis
    • 15.1.6 Key Developments
  • 15.2 Pfizer Inc
    • 15.2.1 Key Facts
    • 15.2.2 Business Description
    • 15.2.3 Products and Services
    • 15.2.4 Financial Overview
    • 15.2.5 SWOT Analysis
    • 15.2.6 Key Developments
  • 15.3 Merck & Co Inc
    • 15.3.1 Key Facts
    • 15.3.2 Business Description
    • 15.3.3 Products and Services
    • 15.3.4 Financial Overview
    • 15.3.5 SWOT Analysis
    • 15.3.6 Key Developments
  • 15.4 Eli Lilly and Co
    • 15.4.1 Key Facts
    • 15.4.2 Business Description
    • 15.4.3 Products and Services
    • 15.4.4 Financial Overview
    • 15.4.5 SWOT Analysis
    • 15.4.6 Key Developments
  • 15.5 ESTEVE
    • 15.5.1 Key Facts
    • 15.5.2 Business Description
    • 15.5.3 Products and Services
    • 15.5.4 Financial Overview
    • 15.5.5 SWOT Analysis
    • 15.5.6 Key Developments
  • 15.6 AstraZeneca Plc
    • 15.6.1 Key Facts
    • 15.6.2 Business Description
    • 15.6.3 Products and Services
    • 15.6.4 Financial Overview
    • 15.6.5 SWOT Analysis
    • 15.6.6 Key Developments
  • 15.7 Sanofi SA
    • 15.7.1 Key Facts
    • 15.7.2 Business Description
    • 15.7.3 Products and Services
    • 15.7.4 Financial Overview
    • 15.7.5 SWOT Analysis
    • 15.7.6 Key Developments
  • 15.8 GSK Plc
    • 15.8.1 Key Facts
    • 15.8.2 Business Description
    • 15.8.3 Products and Services
    • 15.8.4 Financial Overview
    • 15.8.5 SWOT Analysis
    • 15.8.6 Key Developments
  • 15.9 F. Hoffmann-La Roche Ltd
    • 15.9.1 Key Facts
    • 15.9.2 Business Description
    • 15.9.3 Products and Services
    • 15.9.4 Financial Overview
    • 15.9.5 SWOT Analysis
    • 15.9.6 Key Developments
  • 15.10 Novartis AG
    • 15.10.1 Key Facts
    • 15.10.2 Business Description
    • 15.10.3 Products and Services
    • 15.10.4 Financial Overview
    • 15.10.5 SWOT Analysis
    • 15.10.6 Key Developments
  • 15.11 AbbVie Inc
    • 15.11.1 Key Facts
    • 15.11.2 Business Description
    • 15.11.3 Products and Services
    • 15.11.4 Financial Overview
    • 15.11.5 SWOT Analysis
    • 15.11.6 Key Developments
  • 15.12 Teva Pharmaceutical Industries Ltd
    • 15.12.1 Key Facts
    • 15.12.2 Business Description
    • 15.12.3 Products and Services
    • 15.12.4 Financial Overview
    • 15.12.5 SWOT Analysis
    • 15.12.6 Key Developments

16. Appendix

  • 16.1 About The Insight Partners
  • 16.2 Glossary of Terms

List Of Tables

  • Table 1. Prescription Drugs Market Segmentation
  • Table 2. Key Brands Facing Patent Expirations
  • Table 3. North America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 4. North America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 5. North America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 6. North America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 7. North America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 8. North America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 9. North America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 10. North America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 11. North America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 12. North America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 13. United States: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 14. United States: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 15. United States: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 16. United States: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 17. United States: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 18. United States: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 19. United States: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 20. United States: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 21. United States: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 22. United States: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 23. Canada: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 24. Canada: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 25. Canada: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 26. Canada: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 27. Canada: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 28. Canada: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 29. Canada: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 30. Canada: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 31. Canada: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 32. Canada: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 33. Mexico: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 34. Mexico: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 35. Mexico: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 36. Mexico: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 37. Mexico: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 38. Mexico: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 39. Mexico: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 40. Mexico: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 41. Mexico: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 42. Mexico: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 43. Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 44. Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 45. Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 46. Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 47. Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 48. Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 49. Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 50. Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 51. Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 52. Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 53. Germany: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 54. Germany: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 55. Germany: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 56. Germany: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 57. Germany: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 58. Germany: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 59. Germany: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 60. Germany: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 61. Germany: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 62. Germany: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 63. United Kingdom: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 64. United Kingdom: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 65. United Kingdom: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 66. United Kingdom: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 67. United Kingdom: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 68. United Kingdom: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 69. United Kingdom: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 70. United Kingdom: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 71. United Kingdom: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 72. United Kingdom: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 73. France: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 74. France: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 75. France: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 76. France: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 77. France: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 78. France: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 79. France: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 80. France: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 81. France: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 82. France: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 83. Italy: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 84. Italy: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 85. Italy: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 86. Italy: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 87. Italy: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 88. Italy: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 89. Italy: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 90. Italy: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 91. Italy: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 92. Italy: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 93. Spain: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 94. Spain: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 95. Spain: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 96. Spain: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 97. Spain: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 98. Spain: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 99. Spain: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 100. Spain: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 101. Spain: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 102. Spain: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 103. Rest of Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 104. Rest of Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 105. Rest of Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 106. Rest of Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 107. Rest of Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 108. Rest of Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 109. Rest of Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 110. Rest of Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 111. Rest of Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 112. Rest of Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 113. Asia Pacific: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 114. Asia Pacific: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 115. Asia Pacific: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 116. Asia Pacific: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 117. Asia Pacific: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 118. Asia Pacific: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 119. Asia Pacific: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 120. Asia Pacific: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 121. Asia Pacific: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 122. Asia Pacific: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 123. China: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 124. China: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 125. China: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 126. China: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 127. China: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 128. China: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 129. China: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 130. China: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 131. China: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 132. China: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 133. Japan: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 134. Japan: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 135. Japan: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 136. Japan: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 137. Japan: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 138. Japan: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 139. Japan: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 140. Japan: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 141. Japan: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 142. Japan: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 143. India: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 144. India: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 145. India: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 146. India: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 147. India: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 148. India: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 149. India: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 150. India: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 151. India: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 152. India: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 153. Australia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 154. Australia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 155. Australia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 156. Australia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 157. Australia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 158. Australia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 159. Australia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 160. Australia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 161. Australia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 162. Australia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 163. South Korea: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 164. South Korea: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 165. South Korea: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 166. South Korea: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 167. South Korea: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 168. South Korea: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 169. South Korea: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 170. South Korea: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 171. South Korea: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 172. South Korea: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 173. Rest of APAC: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 174. Rest of APAC: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 175. Rest of APAC: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 176. Rest of APAC: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 177. Rest of APAC: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 178. Rest of APAC: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 179. Rest of APAC: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 180. Rest of APAC: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 181. Rest of APAC: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 182. Rest of APAC: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 183. Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 184. Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 185. Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 186. Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 187. Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 188. Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 189. Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 190. Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 191. Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 192. Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 193. Saudi Arabia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 194. Saudi Arabia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 195. Saudi Arabia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 196. Saudi Arabia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 197. Saudi Arabia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 198. Saudi Arabia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 199. Saudi Arabia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 200. Saudi Arabia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 201. Saudi Arabia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 202. Saudi Arabia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 203. South Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 204. South Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 205. South Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 206. South Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 207. South Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 208. South Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 209. South Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 210. South Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 211. South Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 212. South Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 213. United Arab Emirates: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 214. United Arab Emirates: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 215. United Arab Emirates: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 216. United Arab Emirates: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 217. United Arab Emirates: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 218. United Arab Emirates: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 219. United Arab Emirates: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 220. United Arab Emirates: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 221. United Arab Emirates: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 222. United Arab Emirates: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 223. Rest of Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 224. Rest of Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 225. Rest of Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 226. Rest of Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 227. Rest of Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 228. Rest of Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 229. Rest of Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 230. Rest of Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 231. Rest of Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 232. Rest of Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 233. South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 234. South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 235. South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 236. South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 237. South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 238. South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 239. South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 240. South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 241. South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 242. South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 243. Brazil: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 244. Brazil: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 245. Brazil: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 246. Brazil: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 247. Brazil: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 248. Brazil: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 249. Brazil: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 250. Brazil: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 251. Brazil: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 252. Brazil: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 253. Argentina: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 254. Argentina: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 255. Argentina: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 256. Argentina: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 257. Argentina: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 258. Argentina: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 259. Argentina: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 260. Argentina: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 261. Argentina: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 262. Argentina: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 263. Rest of South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 264. Rest of South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 265. Rest of South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 266. Rest of South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 267. Rest of South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 268. Rest of South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 269. Rest of South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 270. Rest of South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 271. Rest of South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 272. Rest of South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 273. Heat Map Analysis by Key Players
  • Table 274. Recent Organic Growth Strategies in the Prescription Drugs Market
  • Table 275. Recent Inorganic Growth Strategies in the Prescription Drugs Market
  • Table 276. Glossary of Terms, Medical Cables Market

List Of Figures

  • Figure 1. Prescription Drugs Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Prescription Drugs Market Revenue (US$ Billion), 2021-2031
  • Figure 5. Prescription Drugs Market Revenue (US$ Billion) Forecast Analysis, 2021-2031
  • Figure 6. Prescription Drugs Market Share (%) - by Product Type (2024 and 2031)
  • Figure 7. Branded: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 8. Generics: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 9. Prescription Drugs Market Share (%) - by Drug Type (2024 and 2031)
  • Figure 10. Small Molecule: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 11. Biologics and Biosimilar: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 12. Prescription Drugs Market Share (%) - by Therapeutic Area (2024 and 2031)
  • Figure 13. Oncology: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 14. Cardiovascular Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 15. Neurological Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 16. Metabolic Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 17. Respiratory Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 18. Immunology: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 19. Others: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 20. Prescription Drugs Market Share (%) - by Route Of Administration (2024 and 2031)
  • Figure 21. Oral: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 22. Injectable: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 23. Topical: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 24. Others: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 25. Prescription Drugs Market Share (%) - by Distribution Channel (2024 and 2031)
  • Figure 26. Hospital Pharmacies: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 27. Retail Pharmacies: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 28. Online Pharmacies: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 29. North America: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
  • Figure 30. North America: Prescription Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 31. United States: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 32. Canada: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 33. Mexico: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 34. Europe: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
  • Figure 35. Europe: Prescription Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 36. Germany: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 37. United Kingdom: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 38. France: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 39. Italy: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 40. Spain: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 41. Rest of Europe: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 42. Asia Pacific: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
  • Figure 43. Asia Pacific: Prescription Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 44. China: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 45. Japan: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 46. India: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 47. Australia: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 48. South Korea: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 49. Rest of APAC: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 50. Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
  • Figure 51. Middle East and Africa: Prescription Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 52. Saudi Arabia: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 53. South Africa: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 54. United Arab Emirates: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 55. Rest of Middle East and Africa: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 56. South and Central America: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
  • Figure 57. South and Central America: Prescription Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 58. Brazil: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 59. Argentina: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 60. Rest of South and Central America: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 61. Company Positioning & Concentration
  • Figure 62. Growth Strategies in the Prescription Drugs Market